IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 51 a 100 di 199
Titolo Data di pubblicazione Autore(i) File
Synergistic cytotoxic activity of recombinant TRAIL plus the non-genotoxic activator of the p53 pathway nutlin-3 in acute myeloid leukemia cells 1-gen-2007 P., Secchiero; C., Zerbinati; M. G., DI IASIO; E., Melloni; Tiribelli, Mario; V., Grill; G., Zauli
Differential gene expression induction by TRAIL in B chronic lymphocytic leukemia (B-CLL) cells showing high versus low levels of Zap-70 1-gen-2007 P., Secchiero; M. G., DI IASIO; A., Gonelli; E., Barbarotto; E., Melloni; Tiribelli, Mario; C., Chiaruttini; G., Zauli
Case-control study of multidrug resistance phenotype and response to induction treatment including or not Fludarabine in newly diagnosed acute myeloid leukemia patients 1-gen-2007 Malagola, Michele; Damiani, Daniela; Martinelli, Giovanni; Michelutti, Angela; Cesana, Bruno; De Vivo, Antonio; Piccaluga, Pier Paolo; Ottaviani, Emanuela; Candoni, Anna; Geromin, Antonella; Tiribelli, Mario; Fanin, Renato; Testoni, Nicoletta; Lauria, Francesco; Bocchia, Monica; Gobbi, Marco; Pierri, Ivana; Zaccaria, Alfonso; Zuffa, Eliana; Mazza, Patrizio; Priccolo, Giancarla; Gugliotta, Luigi; Bonini, Alessandro; Visani, Giuseppe; Skert, Cristina; Bergonzi, Cesare; Roccaro, Aldo Maria; Fili, Carla; Baccarani, Michele; Russo, Domenico
Imatinib therapy for chronic myeloid leukemia patients who relapse after allogenic stem cell transplantation: a molecular analysis 1-gen-2007 Palandri, F; Amabile, M; Rosti, G; Bandini, G; Benedetti, F; Usala, E; Angelucci, E; Tiribelli, Mario; Fanin, Renato; Martinelli, G; Baccarani, M.
The efficacy of imatinib mesylate in patients with the FIP1L1-PDGFRα-positive hypereosinophilic syndrome. Results of a multicenter prospective study 1-gen-2007 M., Baccarani; D., Cilloni; M., Rondoni; E., Ottaviani; F., Messa; S., Merante; Tiribelli, Mario; F., Buccisano; N., Testoni; E., Gottardi; A., DE VIVO; E., Giugliano; I., Iacobucci; S., Paolini; S., Soverini; G., Rosti; F., Rancati; C., Astolfi; F., Pane; G., Saglio; G., Martinelli
SINGLE DOSE OF PEGYLATED RECOMBINANT FILGRASTIM (PEG-FILGRASTIM) AFTER CONSOLIDATION CHEMOTHERAPY FOR ACUTE MYELOID LEUKEMIA IN FIRST COMPLETE REMISSION 1-gen-2008 A., Candoni; S., Buttignol; Tiribelli, Mario; S., Lovato; E., Simeone; A., Michelutti; Damiani, Daniela; R., Fanin
Front-line treatment of Philadelphia positive chronic myeloid leukemia with Imatinib and Interferon-α: 5-year outcome 1-gen-2008 F., Palandri; I., Iacobucci; F., Castagnetti; N., Testoni; A., Poerio; M., Amabile; M., Breccia; T., Intermesoli; F., Iuliano; G., REGE-CAMBRIN; Tiribelli, M; M., Miglino; F., Pane; Saglio, G.; G., Martinelli; G., Rosti; M., Baccarani
Incidence of bacterial and fungal infections in newly diagnosed acute myeloid leukaemia patients younger than 65 years treated with induction regimens including fludarabine: retrospective analysis of 224 cases 1-gen-2008 Malagola, M.; Peli, A.; Damiani, Daniela; Candoni, A.; Tiribelli, Mario; Martinelli, G.; Piccaluga, P. P.; Paolini, S.; De Rosa, F.; Lauria, F.; Bocchia, M.; Gobbi, M.; Pierri, I.; Zaccaria, A.; Zuffa, E.; Mazza, P.; Priccolo, G.; Gugliotta, L.; Bonini, A.; Visani, G.; Skert, C.; Bergonzi, C.; Roccaro, A. M.; Filì, C.; Fanin, Renato; Baccarani, M.; Russo, D.
INCIDENCE OF BACTERIAL AND FUNGAL INFECTIONS IN NEWLY DIAGNOSED ACUTE MYELOID LEUKAEMIA PATIENTS TREATED WITH INDUCTION REGIMENS INCLUDING FLUDARABINE: RETROSPECTIVE ANALYSIS OF 224 CASES 1-gen-2008 M., Malagola; A., Peli; Damiani, Daniela; A., Candoni; Tiribelli, Mario; G., Martinelli; P. P., Piccaluga; S., Paolini; F., De Rosa; F., Lauria; B., Monica; G., Marco; I., Pierri; A., Zaccaria; E., Zuffa; P., Mazza; G., Priccolo; L., Gugliotta; A., Bonini; G., Visani; C., Skert; C., Bergonzi; A. M., Roccaro; C., Filì; R., Fanin; M., Baccarani; D., Russo
Fludarabine-based induction therapy does not overcome the negative effect of bcrp (ABCG2) overexpression on remission duration in adult de novo acute myeloid leukemia patients 1-gen-2008 Tiribelli, Mario; Geromin, A; Michelutti, A; Cavallin, M; Candoni, A; Toffo letti, E; Chiarvesio, A; Fanin, R; Damiani, Daniela
What is the optimal dosage of valganciclovir as preemptive therapy for CMV infection in allogeneic hematopoietic SC 1-gen-2008 Candoni, A; Simeone, E; Tiribelli, Mario; Pipan, Corrado; Fanin, Renato
Combined treatment of CpG-oligodeoxynucleotide with Nutlin-3 induces strong immune stimulation coupled to cytotoxicity in B-chronic lymphocytic leukemic (B-CLL) cells 1-gen-2008 P., Secchiero; E., Melloni; Tiribelli, M; G., Zauli; A., Gonelli
Brain natriuretic peptide level as marker of cardiac function in imatinib--treated chronic myeloid leukemia patients: no evidence of cardiotoxicity of imatinib therapy. 1-gen-2008 Tiribelli, Mario; Colatutto, A; Marin, L; Barbina, G; Qualizza, U; Damiani, Daniela; Toffoletti, Eleonora; Medeot, M; Candoni, A; Tonutti, E; Sala, P; Fanin, Renato
Gemtuzumab-ozogamicin in combination with fludarabine, cytarabine, idarubicin (FLAI-GO) as induction therapy in CD33-positive AML patients younger than 65 years 1-gen-2008 Candoni, A; Martinelli, G; Toffoletti, Eleonora; Chiarvesio, A; Tiribelli, Mario; Malagola, M; Piccaluga, Pp; Michelutti, A; Simeone, E; Damiani, Daniela; Russo, D; Fanin, Renato
A SIMPLE PROGNOSTIC SCORING SYSTEM FOR NEWLY DIAGNOSED ACUTE LEUKAEMIA PATIENTS WITH NORMAL KARYOTYPE: A RETROSPECTIVE ANALYSIS ON 420 CASES 1-gen-2009 Malagola, M.; Skert, C.; Damiani, Daniela; Candoni, A.; Tiribelli, Mario; Martinelli, G.; Piccaluga, P.; Paolini, S.; Lauria, F.; Bocchia, M.; Gobbi, M.; Pierri, I.; Clavio, M.; Miglino, M.; Zaccaria, A.; Zuffa, E.; Mazza, P.; Priccolo, P.; Gugliotta, L.; Bonini, A.; Visani, G.; Bergonzi, C.; Roccaro, A.; Peli, A.; Filì, C.; Turra, A.; Cattina, F.; Fanin, R.; Baccarani, M.; Russo, D.
FLAIE (FLUDARABINE, CYTARABINE, IDARUBICIN AND ETOPOSIDE) INDUCTION CHEMOTHERAPY FOR ADULT ACUTE MYELOID LEUKEMIA. RESULTS OF A PILOT STUDY 1-gen-2009 Candoni, A.; Tiribelli, Mario; Simeone, E.; Volpetti, S.; Florio, F.; Malagola, M.; Damiani, Daniela; Russo, D.; Fanin, R.
CONCOMITANT OVEREXPRESSION OF BCRP AND FLT3-ITD MUTATION ARE ASSOCIATED WITH POOR PROGNOSIS IN ACUTE MYELOID LEUKEMIA PATIENTS 1-gen-2009 Tiribelli, Mario; Damiani, Daniela; Geromin, A; Pianta, A; Fabbro, D; Michelutti, A; Cavallin, M; Toffoletti, E; Candoni, A; Cerno, M; Damante, Giuseppe; Fanin, Renato
Fludarabine-based induction therapy does not vercome the negative effect of ABCG2 (BCRP) oveerexpression in adult acute myeloid leukemia 1-gen-2009 Tiribelli, Mario; Geromin, A; Michelutti, A; Cavallin, M; Candoni, A; Toffoletti, E; Fanin, R; Damiani, Daniela
Nilotinib for the frontline treatment of Ph(+) chronic myeloid leukemia. 1-gen-2009 Alimena, G; Amabile, M; Baccarani, Michele; Breccia, M; Cambrin, Gr; Capucci, A; Castagnetti, F; Cedrone, M; Fava, C; Gugliotta, G; Intermesoli, T; Levato, L; Luatti, S; Martinelli, Giovanni; Palandri, F; Pane, F; Poerio, A; Rosti, G; Saglio, G; Soverini, S; Stagno, F; Testoni, Nicoletta; Tiribelli, Mario
Reduced expression of cell cycle-associated genes in B lymphocytes purified from the peripheral blood of early-stage B chronic lymphocytic leukaemia patients. 1-gen-2009 DI IASIO, Mg; Secchiero, P; Tiribelli, Mario; Zauli, G.
Nilotinib and donor lymphocyte infusion in the treatment of Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL) relapsing after allogeneic stem cell transplantation and resistant to imatinib 1-gen-2009 Tiribelli, Mario; Sperotto, A; Candoni, A; Simeone, E; Buttignol, S; Fanin, Renato
A simple Prognostic Scoring System for newly diagnosed acute leukaemia patients with normal karyotype: a retrospective analysis on 173 cases. 1-gen-2009 Malagola, M.; C., Skert; Damiani, Daniela; A., Candoni; Tiribelli, Mario; G., Martinelli; P. P., Piccaluga; S., Paolini; F., Lauria; M., Bocchia; M., Gobbi; M., Clavio; M., Miglino; I., Pierri; A., Zaccaria; E., Zuffa; P., Mazza; G., Priccolo; L., Gugliotta; A., Bonini; G., Visani; A., Isidori; C., Bergonzi; A. M., Roccaro; A., Peli; C., Filì; R., Fanin; 2 M., Baccarani; D., Russo
Quantitative assessment of WT1 gene expression after allogeneic stem cell transplantation is a useful tool for monitoring minimal residual disease in acute myeloid leukemia. 1-gen-2009 Candoni, A.; Tiribelli, Mario; Toffoletti, E.; Cilloni, D.; Chiarvesio, A.; Michelutti, A.; Simeone, E.; Pipan, C.; Saglio, G.; Fanin, R.
Time trend in cancer incidence among 0-24 year-old residents of the Province of Trieste, Italy, 1972-2003 1-gen-2009 Brunetti, Davide; Tamaro, Paolo; Tiribelli, Mario; Fanin, Renato; Stanta, Giorgio; Zanazzo, Giulio Andrea; Peruzzo, Paolo; Carobolante, Francesca; Kiren, Valentina; Serraino, Diego
FLAIE (fludarabine, cytarabine, idarubicin, and etoposide), a four drug induction chemotherapy for adult acute myeloid leukemia: A single center experience 1-gen-2009 Candoni, A; Simeone, E; Tiribelli, Mario; Malagola, M; Russo, D; Fanin, Renato
Fludarabine-based induction therapy does not overcome the negative effect of ABCG2 (BCRP) over-expression in adult acute myeloid leukemia patients. 1-gen-2009 Tiribelli, Mario; Geromin, A.; Michelutti, A.; Cavallin, M.; Candoni, A.; Toffoletti, E.; Fanin, R.; Damiani, Daniela
Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism. 1-gen-2009 Secchiero, P; Melloni, E; DI IASIO, Mg; Tiribelli, Mario; Rimondi, E; Corallini, F; Gattei, V; Zauli, G.
Unexpected phenotype of a typical NPM1 mutant 1-gen-2009 Pianta, Annalisa; Fabbro, D; Damiani, Daniela; Tiribelli, Mario; Fanin, Renato; Franzoni, A; Romanello, Milena; Tell, Gianluca; Damante, Giuseppe
Treatment of Philadelphia-positive chronic myeloid leukemia with imatinib: importance of a stable molecular response. 1-gen-2009 Abruzzese, E; Alimena, G; Baccarani, Michele; Breccia, M; Castagnetti, F; Iacobucci, I; Luciano, L; Martinelli, Giovanni; Martino, B; Palandri, F; Pane, F; Poerio, A; REGE CAMBRIN, G; Rosti, G; Saglio, G; Soverini, S; Testoni, Nicoletta; Tiribelli, Mario; Varaldo, R.
5-AZACITIDINE FIVE DAYS/MONTHLY SCHEDULE IN SYMPTOMATIC LOW-RISK (IPSS: 0-1) MYELODISPLASTIC (MDS) PATIENTS. CLINICAL AND BIOLOGICAL EFFECTS Authors 1-gen-2010 C., Filì; 1 M., Gobbi; 2 G., Martinelli; 3 C., Finelli; 4 I., Iacobucci; 5 E., Ottaviani; 5 L., Cocco; 6 M., Follo; 6 A., Candoni; 7 E., Simeone; Damiani, Daniela; Tiribelli, Mario; 7 M., Miglino; 2 F., Lauria; 8 M., Bocchia; 8 M., Defina; 8 C., Clissa; 9 C., Skert; 10 C., Bergonzi; 10 M., Malagola; 10 A., Peli; 10 A., Turra; 10 F., Cattina; 10 C., Colombi; 10 D., Russo10
Fludarabine-based induction therapy does not overcome the negative effect of ABCG2 (BCRP) over-expression in adult acute myeloid leukemia patients 1-gen-2010 Damiani, Daniela; Tiribelli, Mario; Michelutti, A; Geromin, A; Cavallin, M; Fabbro, D; Pianta, A; Malagola, M; Damante, Giuseppe; Russo, D; Fanin, Renato
CONCOMITANT BCRP OVER-EXPRESSION AND FLT3-ITD MUTATION IDENTIFY A SUBSET OF ACUTE MYELOID LEUKEMIA PATIENTS AT HIGH RISK OF RELAPSE 1-gen-2010 Tiribelli, Mario; Damiani, Daniela; Geromin, A.; Michelutti, 1 A.; Cavallin, 1 M.; Pianta, 1 A.; Fabbro, 2 D.; Candoni, 2 A.; Toffoletti, 1 E.; Cerno, 1 M.; Marin, 1 L.; Damante, Giuseppe; Fanin, Renato
Two novel NMP1 mutations in a therapy-responder AML patiente 1-gen-2010 Pianta, A; Fabbro, D; Damiani, Daniela; Tiribelli, Mario; Fanin, Renato; Franzoni, A; Romanello, M; Tell, Gianluca; DI LORETO, Carla; Damante, Giuseppe
QUANTITATIVE ANALYSIS OF MN1 GENE EXPRESSION FOR EVALUATION OF MINIMAL RESIDUAL DISEASE IN CYTOGENETICALLY NORMAL ACUTE MYELOID LEUKEMIA PATIENTS 1-gen-2010 Tiribelli, Mario; Toffoletti, E.; Gallina, R.; Damiani, Daniela; Candoni, A.; Fanin, R.
The expression levels of the pro-apoptotic XAF-1 gene modulate the cytotoxic response to Nutlin-3 in B chronic lymphocytic leukemia. 1-gen-2010 Celeghini, C; DAL BO, M; DI IASIO, Mg; Gattei, V; Melloni, Elisabetta; Secchiero, P; Tiribelli, Mario; Voltan, R; Zauli, G.
The oncogene DEK promotes leukemic cell survival and is downregulated by both Nutlin-3 and chlorambucil in B-chronic lymphocytic leukemic cells. 1-gen-2010 DI IASIO, Mg; Melloni, Elisabetta; Secchiero, P; Tiribelli, Mario; Voltan, R; Zauli, G.
Dasatinib is safe and effective in unselected chronic myeloid leukaemia elderly patients resistant/intolerant to imatinib 1-gen-2011 R., Latagliata; M., Breccia; F., Castagnetti; F., Stagno; L., Luciano; A., Gozzini; S., Ulisciani; F., Cavazzini; M., Annunziata; F., Sorà; A., RUSSO ROSSI; P., Pregno; E., Montefusco; E., Abruzzese; E., Crisà; P., Musto; Tiribelli, Mario; G., Binotto; U., Occhini; C., Feo; P., Vigneri; V., Santini; C., Fava; G., Rosti; G., Alimena
Concomitant ABCG2 overexpression and FLT3-ITD mutation identify a subset of acute myeloid leukemia patients at high risk of relapse 1-gen-2011 Tiribelli, Mario; A., Geromin; A., Michelutti; M., Cavallin; A., Pianta; D., Fabbro; D., Russo; Damante, Giuseppe; Fanin, Renato; Damiani, Daniela
Nutlin-3 down-regolates the expression of the oncogene TCL1 in primary B chronic lymphocytic leukemic (B-CLL) cells 1-gen-2011 R., Voltan; M. G., DI IASIO; R., Bosco; N., Valeri; Y., Pekarski; Tiribelli, Mario; P., Secchiero; G., Zauli
Frontline imatinib treatment of chronic myeloid leukemia: no impact of age on outcome, a survey by the GIMEMA CML WP 1-gen-2011 G., Gugliotta; F., Castagnetti; F., Palandri; M., Breccia; T., Intermesoli; A., Capucci; B., Martino; P., Pregno; S., Rupoli; D., Ferrero; F., Gherlinzoni; E., Montefusco; M., Bocchia; Tiribelli, Mario; I., Pierri; F., Grifoni; G., Marzocchi; M., Amabile; N., Testoni; G., Martinelli; G., Alimena; F., Pane; G., Saglio; M., Baccarani; G., Rosti
Cardiotoxicity of imatinib: at the heart of the problem 1-gen-2011 Tiribelli, Mario; M., Medeot
Donor compatibility and performance status affect outcome of allogeneic haematopoietic stem cell transplant in patients with relapsed or refractory acute myeloid leukaemia 1-gen-2012 Damiani, Daniela; Tiribelli, Mario; Geromin, A; Cerno, M; Sperotto, A; Toffoletti, Eleonora; Simeone, A; Michelutti, M; Cavallin, M; Fanin, Renato
Investigating factors associated with adherence behavior in patients with chronic myeloid leukemia. An observational patient-centered outcome study 1-gen-2012 Efficace, F; Baccarani, M; Rosti, G; Cottone, F; Castagnetti, F; Breccia, M; Alimena, G; Iurlo, A; Rossi, Ar; Pardini, S; Gherlinzoni, F; Salvucci, M; Tiribelli, M; Vignetti, M; Mandelli, F
Tyrosine kinase inhibitors for elderly chronic myeloid leukemia patients: a systematic review of efficacy and safety data 1-gen-2012 Breccia, M; Tiribelli, Mario; Alimena, G.
The Sorafenib plus Nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of the FLT3 and p53 status. 1-gen-2012 Zauli, G; Celeghini, C; Melloni, E; Voltan, R; Ongari, M; Tiribelli, Mario; di Iasio, Mg; Lanza, F; Secchiero, P.
Evaluation of residual CD34+ Ph+ progenitor cells in chronic myeloid leukemia patients who have complete cytogenetic response during first-line nilotinib therapy 1-gen-2012 Defina, M; Ippoliti, M; Gozzetti, A; Abruzzese, E; Castagnetti, F; Crupi, R; Tiribelli, Mario; Breccia, M; Salvucci, M; Aprile, L; Baratè, C; Gozzini, A; Rosti, G; Lauria, F; Bocchia, M.
Histone post-translational modifications associated to BAALC expression in leukemic cells. 1-gen-2012 Franzoni, Alessandra; Passon, Nadia; Fabbro, Dora; Tiribelli, Mario; Damiani, Daniela; Damante, Giuseppe
Q141K polymorphism of ABCG2 protein is associated with poor prognosis in adult acute myeloid leukemia treated with idarubicin-based chemotherapy. 1-gen-2013 Tiribelli, Mario; Fabbro, D; Franzoni, A; Fanin, Renato; Damante, Giuseppe; Damiani, Daniela
BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients 1-gen-2013 Damiani, Daniela; Tiribelli, Mario; Franzoni, A; Michelutti, A; Fabbro, Dora; Cavallin, M; Toffoletti, Eleonora; Simeone, Erica; Fanin, Renato; Damante, Giuseppe
Imatinib in very elderly patients with chronic myeloid leukemia in chronic phase: a retrospective study. 1-gen-2013 Latagliata, R; Ferrero, D; Iurlo, A; Cavazzini, F; Castagnetti, F; Abruzzese, E; Fava, C; Breccia, M; Annunziata, M; Stagno, F; Tiribelli, Mario; Binotto, G; Mansueto, G; Gozzini, A; Russo, S; Cavalli, L; Montefusco, E; Gugliotta, G; Cedrone, M; Russo Rossi, A; Avanzini, P; Pregno, P; Mauro, E; Spadea, A; Celesti, F; Giglio, G; Isidori, A; Crugnola, M; Calistri, E; Sorà, F; Storti, S; D'Addosio, A; Rege Cambrin, G; Luciano, L; Alimena, G.
Mostrati risultati da 51 a 100 di 199
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile